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Abstract Acylated pardaxin is translocated through the cyto-
plasmic membrane and is accumulated in the nucleoli of NG108-
15 and chromaffin cells. The uptake is time- and dose-dependent
and temperature-sensitive. However, the binding of acylated
125I-pardaxin cannot be reduced by competition with pardaxin
acylated with Rudinger’s reagent. In this respect, acylated
pardaxin resembles the Tat protein 37^71 fragment. Metabolic
inhibitors do not significantly reduce the uptake of acylated 125I-
pardaxin. Acylated pardaxin might be useful as a vector to
translocate other molecules.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The soles of the genus Pardachirus Gunther exude secre-
tions into the sea water that are toxic to other ¢sh [1,2] and
repel sharks [3^5]. The secretions contain ichthyotoxic pep-
tides named pardaxins [6]. So far, ¢ve pardaxins have been
identi¢ed and sequenced. Three were found in the species
Pardachirus pavoninus [7] and another two in Pardachirus
marmoratus [8,9]. All pardaxins are composed of 33 amino
acids and form an N-terminal hydrophobic helix (residues
2^10) linked by Ser-Pro to a C-terminal amphiphilic helix
(residues 13^27). In aqueous solutions, pardaxin peptides
were found in both monomeric and oligomeric forms [10^
12]. When pardaxin monomers are inserted into arti¢cial
phospholipid membranes or into plasma membranes, they as-
semble like barrel staves, forming pores with low ionic selec-
tivity [10^19]. Cytolysis follows the pore formation [10]. Acyl-
ation of the N-terminal amino group at Gly1 leaves intact the
insertion into membranes but reduces the cytolytic (i.e. hemo-
lytic) activity more than 70-fold [20]. A virtually complete loss
of hemolytic activity occurs after acylation of pardaxin with
acetic anhydride [21] or Rudinger’s reagent [9]. The present
experiments originated from our observation that acylated
pardaxin reduces the permeability of NG108-15 cells (Fig.
1). So we considered that acylated pardaxin may be bound
by and then translocated through cytoplasmic membranes,
and that therefore pardaxin might be useful as a vector to
translocate other molecules. Here we present data on the
binding and translocation of acylated pardaxin.
2. Materials and methods
Bovine chroma⁄n cells were prepared from suprarenal glands re-
moved from calves within 5 min after slaughter. The source culture of
NG108-15 neurohybridoma cells was a gift of Dr. W. Klee, NIMH,
Bethesda, MD, USA. T25adh cells were derived from S-49 mouse
lymphoma cells [22,23]. The cells were prepared and maintained as
described (lymphoma cells [23], chroma⁄n cells [24], NG108-15 cells
[25]). Leu5-Leu14-Asp31-pardaxin (P5 [9]), GFFALIPKIISSPLFKT-
LLSAVGSALSSSGDQE, was either puri¢ed from the secretion of
Pardachirus marmoratus or synthesized as described [9]. Succinimid-
yl-3-(3-125I-4-hydroxy)phenylpropionate (Bolton-Hunter reagent) was
from Amersham (Little Chalfont, UK); iminothiolane (ITH), sulfo-
succinimidyl-3-(4-hydroxy)phenylpropionate (Rudinger’s reagent,
SHPP), sulfosuccinimidyl-6-[3P-(2-pyridyldithio)propionamido]hexa-
noate (slcSPDP) and sulfosuccinimidyl-4-(N-maleimidomethyl)cyclo-
hexane-1-carboxylate (sSMCC) were from Pierce (Rockford, IL);
2P,7P-bis-(2-carboxyethyl)-5- (and -6-)carboxy£uorescein acetoxymeth-
ylester (BCECF-AM), pyrenyldiazomethane (PYR), and monosucci-
nimidyl Cy3 were from Molecular Probes (Eugene, OR, USA). All
other chemicals and the culture media were of the highest quality
available.
2.1. Synthesis of Cy3-pardaxin
The lyophilized content of one vial of monosuccinimidyl-Cy3
(about 250 Wg or 326 nmol) was dissolved in 184 Wl of a 0.1 M sodium
bicarbonate solution containing 184 Wg (54 nmol) pardaxin. The sol-
ution was agitated overnight. The £uorescent reaction product was
puri¢ed by HPLC on a Vydac C18 reverse-phase column (250U4.6
mm, 5 Wm, 300 Aî ) [9].
2.2. Synthesis of HPP-pardaxin
Pardaxin (53.2 nmol) was reacted overnight with SHPP (1.07 Wmol)
in 103 Wl 0.1 M borate bu¡er, pH 8.5. The reaction product was
puri¢ed by HPLC.
2.3. Synthesis of 125 I-HPP-pardaxin
One nanomol pardaxin, dissolved in 60 Wl of 0.1 M borate, pH 8.5,
was added to 0.5 nmol (1 mCi) of Bolton-Hunter reagent. The reac-
tion vessel was rotated. After 1 h, 20 nmol of SHPP in 10 Wl borate
bu¡er was added to acylate the remaining primary amino groups.
Three days were allowed for the hydrolysis of the remaining free
succinimidyl groups of SHPP not coupled to pardaxin.
2.4. Synthesis of MCC-pardaxin and PDP-pardaxin
The reaction mix contained 4 mM pardaxin and 40 mM (in two
syntheses 80 mM) sSMCC or slcSPDP, respectively, in DMSO. The
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reaction time was at least 3 h. The ensuing MCC-pardaxin or PDP-
pardaxin derivatives were puri¢ed by centrifugation through Sepha-
dex G-25 F swollen either in PBS or 0.1 M borate bu¡er at pH 8.5. In
the PBS ¢ltrates, they were deactivated with mercaptoethanol or cys-
teine. In the borate ¢ltrates, they were mixed with iminothiolane-thio-
lated proteins (transferrin or human IgG). At least one day was al-
lowed for the protein-disul¢de exchange between PDP-pardaxin and
thiolated protein. The pardaxin-protein (i.e. IgG, transferrin) conju-
gates were puri¢ed by centrifugation through Sephadex G-25 F swol-
len in PBS.
2.5. Synthesis of PYR-pardaxin
Equal volumes of pardaxin 2.5 mM in DMSO and PYR 2.5 mM in
DMSO were mixed and allowed to react for 2 h. The reaction mix was
centrifuged through Sephadex G-25 F swollen in DMSO. The £uo-
rescent PYR labeled pardaxin at its carboxyl groups. In the syntheses
of the pardaxin-protein conjugates, PYR-pardaxin was added to par-
daxin to permit the determination of the pardaxin/protein ratio. The
concentration of PYR-pardaxin was 1/100 of the pardaxin concentra-
tion.
2.6. Light microscopic visualization of cells incubated with
Cy3-pardaxin
The cells were plated at a density of 105 cells/200 mm2 on cover
glasses coated with collagen. NG108-15 cells were incubated for 4 h
and chroma⁄n cells for 16 h with Cy3-pardaxin. Two concentrations
(25 or 100 nM) were used. All cells were then washed twice with PBS,
¢xed with 4% bu¡ered formaldehyde for half an hour, washed twice
with PBS, covered with glycerol and stored at 4‡C. Normal £uores-
cence and Nomarski photography was done with a Zeiss Axiovert
microscope.
2.7. Confocal microscopy
A Bio-Rad MRC-1024 confocal scanhead coupled to a Zeiss Axi-
overt 135M inverted microscope was used to acquire images of the
stained cells, with a 63U oil objective (numerical aperture 1.4). Ex-
citation light was provided by a 100 mw air-cooled argon ion laser run
in the multi-line mode. The cells were labeled with Cy3-pardaxin. The
data presented in this report were obtained using 514 nm excitation.
The emission ¢lter in the Cy3 detection channel was either a 585LP
low pass ¢lter (585 nm, 50% point) or an HQ570/30 (570 þ 15 nm)
interference ¢lter. The iris aperture was 2.5 mm. In addition, the
emission was detected simultaneously in a second channel, using ei-
ther a 540/30 bandpass ¢lter (540 þ 15 nm) or an HQ535/20 bandpass
¢lter (535 þ 10 nm). This channel was used to provide an internal
control against auto£uorescence, as explained below. Images of
512U512 pixels were acquired, and a 3U3 median ¢lter was used to
remove point noise from the digital images. A linear contrast stretch
was applied to enhance contrast. Unstained controls were found to
produce a green/yellow auto£uorescence when excited at 488 nm. This
auto£uorescence decreased by at least a factor of 4 when excited with
514 nm under identical detection conditions. In order to determine
that the emission which was observed was due primarily to Cy3, the
images were obtained both at 488 nm and 514 nm in both emission
channels. The short wavelength channel was dominated by auto£uor-
escence, while the long wavelength channel detected Cy3 much more
e⁄ciently, and perhaps also auto£uorescence. In order to rule out
auto£uorescence, the images obtained at 514 nm were compared to
those obtained using 488 nm. At 514 nm, the response of the short
wavelength channels decreased, while the long wavelength channel
either remained una¡ected or showed some increase in signal.
Although it is possible that Cy3 emission bled through the 540/30
¢lter, this channel still provided an upper limit on auto£uorescence.
Thus, while it is likely that some auto£uorescence is detected (at least
through the HQ570/30 ¢lter), it represents only a small part of the
detected signal.
2.8. Binding and translocation studies
NG108-15 cells were plated on 24-well plates (105 cells/well) and
maintained for two days at a low (1%) FCS concentration. They were
incubated with various solutions at 37‡C or 0‡C for 2 h. A combina-
tion of deoxy-D-glucose 25 mM, NaCN 10 mM and NaN3 100 mM in
isotonic saline was used for metabolic inhibition. After incubation, the
cells were washed twice with cold PBS, harvested and centrifuged. The
pellet was again washed with cold PBS and was counted in a gamma
counter.
2.9. Permeability of the cytoplasmic membrane
NG108-15 cells were plated on 24-well plates (105 cells/well) and
were maintained at a 1% FCS concentration for two days. The con-
tent of a BCECF-AM vessel (50 Wg) was dissolved in 30 Wl DMSO
and further diluted into 6.1 ml serum-free equilibrated DBME. The
cells were washed twice with this medium, covered with 250 Wl
BCECF-AM dilution/well and returned to the incubator. After 30
min, they were washed twice with 37‡C HEPES medium (25 mM
HEPES, 110 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM
MgCl2, 25 mM glucose, adjusted to pH 7.5 with NaOH), covered
with pardaxin or pardaxin derivatives dissolved in HEPES medium
(500 Wl/well), and returned to the incubator for 15 min. The super-
natants were then removed and pressed through glass ¢lters. The
¢ltrates were diluted 1+4 with HEPES medium, the £uorescence of
the dilutions was excited at the 505-nm optimum and at the 439-nm
isosbestic point, and was recorded at 535 nm. The isosbestic correc-
tion had virtually no in£uence on the results.
2.10. Cytolysis
T25adh cells were plated on 24-well plates. Two hours later, the
cells were incubated with pardaxin or one of its derivatives. After 45
and 120 min of incubation, a person not knowing the protocol ranked
the degree of damage to the cells into ¢ve categories.
2.11. Peptide and protein determination
The peptide content of the pardaxin derivative solutions and the
protein content of cell solubilisates were determined with the Sigma
BCA assay, using as a standard either synthetic pardaxin (for the
pardaxin derivatives) or BSA.
3. Results
3.1. Action on the permeability of cytoplasmic membranes
At low concentrations, pardaxin and acyl-pardaxin de-
creased the spontaneous leakage of £uorescent BCECF from
FEBS 21143 30-11-98
Fig. 1. Action of pardaxin (open circles) and acylated pardaxin
(¢lled circles) on BCECF release from NG108-15 cells.
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NG108-15 cells (Fig. 1). At elevated concentrations, only par-
daxin increased the BCECF leakage.
3.2. Intracellular detection of Cy3-pardaxin
With confocal microscopy, Cy3-pardaxin was detected in-
side NG108-15 cells (Fig. 2) and inside chroma⁄n cells (not
shown). After 4 h of incubation, the intensity of £uorescence
was smaller in chroma⁄n cells than in NG108-15 cells. The
glia cells had a stronger £uorescence than the chroma⁄n cells.
Structural elements (nucleoli) inside the nuclei were heavily
labeled. This strong £uorescence was consistently found in
several cells of the same cover slip as well as in cells from
cover slips of another experiment. On scanning, £uorescent
spots were seen in the cytoplasm, some of which had a vesic-
ular shape. Fluorescence of the plasma membrane was ob-
vious particularly in the top sections, where the membrane
looked like a £uorescent cap. Fluorescent ‘parcels’ could be
seen in the dendrites of NG108-15 cells. NG108-15 cells from
the same cover slip showed di¡erent intensities of £uores-
cence. No cell damage exceeding the controls was detected
in either the NG108-15 or the chroma⁄n cells.
3.3. Binding and translocation
At 37‡C, binding plus translocation of 125I-HPP-pardaxin
was dose-dependent (Fig. 3) and reached equilibrium after
more than 2 h. However, in a competitive experiment, this
accumulation was not reduced with the 1000-fold concentra-
tion of ‘cold’ HPP-pardaxin (data not shown). Binding plus
translocation of acylated 125I-pardaxin was time-dependent
and was much lower at 0‡C than at 37‡C (Fig. 4), and meta-
bolic inhibitors did not signi¢cantly reduce its uptake (data
not shown).
3.4. Cytolysis
Pardaxin at a concentration of 20 mM produced complete
cytolysis in T25adh-cells. Pardaxin acylated with either
slcSPDP or sSMCC and then deactivated with mercaptoetha-
nol had lost its cytotoxicity (data not shown).
4. Discussion
Acylated pardaxin is not only inserted into cytoplasmic
membranes [10,17], but is translocated and accumulated in
the nucleus. The binding of acylated pardaxin is not a classical
high a⁄nity receptor binding because no binding constants or
number of binding sites could be determined with a Scatchard
experiment. However, this distinctive kind of non-competitive
peptide binding has already been described for the Tat protein
37^72 fragment [26] and for the Drosophila antennapedia ho-
meodomain (Antp-HD, [27]). The binding of the 125I-Tat frag-
ment is even increased by cold Tat fragment. In contrast,
acylated pardaxin does not increase the binding of acylated
125I-pardaxin. The translocation of acylated pardaxin is tem-
perature-sensitive. The £uorescent vesicular structures appear-
ing in the cytoplasm of NG108 as well as of chroma⁄n cells
point to an uptake via endocytosis or pinocytosis, but the
binding experiments as well as the experiments with metabolic
inhibitors lend no support to this hypothesis. Therefore, the
uptake mechanism and the vesicle structure need further char-
acterization. Because both the Tat peptide fragment and the
Antp-HD are translocated, they are used for the introduction
of other peptides, proteins, and oligonucleotides [28,29]. For
the same reason, pardaxin derivatives might be useful as vec-
tors to translocate other molecules.
The cytolytic activity of pardaxin was lost after acylation of
the amino group of Gly1 [20] or of the amino groups in Gly1,
Lys8 and Lys16 [21] with the small succinic anhydride mole-
cule. The present experiments provide additional evidence that
this is due to the acylation of the amino groups rather than to
the introduction of free carboxyl groups with succinic anhy-
dride: upon acylation with any of the reagents Cy3, Cy3.5,
sSMCC, slcSMCC (this paper) or SHPP [9], or on tri-acyla-
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Fig. 3. Dose-dependent binding plus uptake of acylated 125I-pardax-
in by NG108-15 cells at 37‡C.
Fig. 2. Detection of Cy3-acylated pardaxin in NG108-15 cells. Be-
ginning at the bottom of the cell, confocal sections were acquired
using half micron steps. Sections 8^12, acquired over a depth of
about 2.5 Wm, were projected onto the same plane to show several
nucleoli which are not all in the same plane. The inset shows a
single section through a dendrite of another cell.
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tion (Table V in [21]), pardaxin always lost its cytotoxic ac-
tivity.
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Fig. 4. Time-dependent binding plus uptake of 10 nM acylated 125I-
pardaxin by NG108-15 cells at 37‡C (¢lled circles) and 0‡C (¢lled
squares).
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